Clik here to view.
AristaMD’s CMIO: Find the Most Important Question…and Answer It
A chat with AristaMD’s Chief Medical Information Officer Kathleen Myers, MD, FACEP Each year, patients receive nearly 100 million referrals to healthcare specialists, but a majority of these visits...
View ArticleAristaMD Appoints New Leadership to Drive Company’s Next Phase of Growth
LeVasseur, Tatman bring deep healthcare experience to new roles, combined with strategic focus on broad industry adoption AristaMD, whose technology improves the specialty referral process for primary...
View ArticleBreast Cancer Awareness: The Need for Advanced Technologies in the Operating...
While there has been tremendous progress in the development of new cancer therapeutics, there has been much less progress advancing surgical practices that revolutionize care within the operating room....
View ArticleThe Path to Financing: What Three San Diego VCs Wish Entrepreneurs Knew
When it comes to venture capital, there is a finite amount of money being sought by an ever-growing number of innovators and entrepreneurs. The path to successfully securing some of that funding often...
View ArticleAvelas Biosciences Broadens Management Team with Key Executive Additions
SAN DIEGO, January 3, 2018 – Avelas Biosciences, Inc., a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic...
View ArticleClik here to view.
COI’s 2017 Year in Review; Hello 2018
2017: Healthy and Growing Team Looking back over the last twelve months we are grateful to the entire COI community for their dedication to developing impactful innovations for human health. Each year...
View ArticleAvelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of...
SAN DIEGO, January 4, 2018 – Avelas Biosciences, Inc., a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic...
View ArticleClik here to view.
COI Can: World Cancer Day
A reporter recently asked us whether there needed to be more drug development in cancer, since there already seemed to be so many companies and recent breakthroughs in the cancer field. There are 8.8...
View ArticleTighe Reardon, CFO: An Asset Behind the Scenes
With 14 active companies in the COI incubator, impeccable leadership of the finance team and proper management of the $19.7 million in revenue that supports COI portfolio companies is a must. At COI we...
View ArticleSynthorx: Synthetic Biology for Better Medicine
Synthorx is an example of a company with a disruptive technology that was cofounded by Avalon Ventures and is incubated at COI Pharma. The Synthorx expanded genetic alphabet technology enables highly...
View ArticleAHL Interviews Jay Lichter, Bringing NewCos to San Diego
American Healthcare Leader (AHL) interviewed Jay Lichter, Ph.D., to talk to him about why he built a different kind of incubator to start companies in San Diego. About ten years ago, when Jay was a...
View ArticleHow To Name Your Life Science Startup
In 2014, a promising young immuno-oncology startup named Alinos was incorporated. It had a great team and great technology. Unfortunately, the crew hadn’t yet established the website. When it came time...
View ArticleFortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel...
SAN DIEGO, November 6, 2018 – Fortis Therapeutics, Inc., an immuno-oncology biotech developing a novel antibody-drug conjugate (ADC) against CD46, today announced the U.S. Food and Drug Administration...
View ArticleClik here to view.
That’s a wrap on 2018…hello 2019!
2018 was a great year for COI startups. Here were our company milestones, funding successes, honors and more. Money raises It seems 2018 was Synthorx’s year. With its new president and CEO, Laura...
View ArticleAvalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari...
GSK to obtain transglutaminase 2 small molecule program for celiac disease SAN DIEGO, September 11, 2019 – Avalon Ventures today announced that it entered into a definitive agreement with...
View ArticleCOI Pharmaceuticals Announces Acquisition of Calporta by Merck
SAN DIEGO, November 13, 2019 – COI Pharmaceuticals, the Community Of Innovation established by Avalon Ventures, today announced the acquisition of Calporta Therapeutics, Inc. by Merck, known as MSD...
View ArticleSanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5...
Proprietary immuno-oncology (IO) platform synergistic with Sanofi’s existing therapeutic platforms Lead asset THOR-707 (“not-alpha” IL-2) being explored across multiple solid tumor types alone and in...
View ArticleeConsult solution company AristaMD secures $18 million in Series B funding
MemorialCare Innovation Fund and Cigna Ventures Lead Financing for Best-in-Class AristaMD eConsult Platform SAN DIEGO – March 31, 2020 – AristaMD, a digital health company that provides a proprietary...
View ArticleeConsult Solution Company AristaMD Adds Ascension Ventures and .406 Ventures...
SAN DIEGO, July 14, 2020 – AristaMD, a leading digital health company that provides proprietary eConsult solutions that connect primary care providers (PCPs) with timely, documented specialist...
View ArticleAvelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can...
Use of pegloprastide, a fluorescent cancer marker, during surgery correctly identified cancer in up to 75% of patients who would have otherwise been candidates for a repeat (re-excision) surgery...
View Article